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Autosomal dominant polycystic kidney disease and coronary artery dissection or aneurysm: a systematic 
review 
 
 
Abstract 
Importance: Autosomal dominant polycystic kidney disease (ADPKD) has been associated with cardiovascular 
abnormalities such as intracranial and aortic aneuryms.  
Objective: To systematically reviewed case reports and case series of ADPKD patients with coronary artery 
dissection or aneurysm. 
Evidence Review: Systematic review registration number: CRD42015015723. Data sources: MEDLINE, Web of 
Science and OpenGrey. Reference lists of studies. Study selection: Published case reports and case series. Data 
extraction: Two parties analyzed the studies. Disagreements were solved by consensus or by a third party. Funding: 
None 
Findings: The reports of 23 patients (22 from 17 studies – 6 with coronary artery dissection and 16 with coronary 
artery aneurysm – and 1 with coronary dissection here reported) were analyzed. Most patients were symptomatic. 
Coronary dissection showed female and left descending anterior artery predominance, features similar to non-ADPKD 
patients, but a median diagnostic age below expected (41 vs 50 years old). Coronary aneurysms had male and right 
coronary artery predominance but lower median diagnostic age (44 years old) and higher rate of multiple vessel 
affection than reported for non-ADPKD patients.  
Conclusion and relevance: Clinical disparities may suggest a different mechanism of aneurysm formation comparing 
to the population without ADPKD. Nevertheless, lack of access to data of one patient and text of one article limited 
our conclusions. Coronary aneurysms and dissections represent a source of coronary syndromes and death in 
ADPKD. Mutation of ADPKD-related genes may predispose to coronary abnormalities, especially aneurysms. 
Further analysis regarding this association is necessary. 
 
Keywords 
Autosomal dominant polycystic kidney disease, coronary aneurysm, coronary dissection, systematic review.  
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 Introduction 
 Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent hereditary renal cystic 
disease[1]. This monogenic disorder is caused by mutation with loss of function of one of two genes: PKD1, that 
encodes polycystin-1, and PKD2, that encodes polycystin-2[2].  PKD1 mutation is responsible for 85% of cases, and 
PKD2 mutation for the remainder[1].  
 ADPKD is associated with a wide phenotypic range. Manifestations include renal, hepatic, pancreatic, 
seminal vesicle and arachnoid cysts, intracranial and aortic aneurysms, cardiac valvular abnormalities, colonic 
diverticula, and bronchiectasis[3]. Although apparently rare, arterial aneurysms and dissections on other locations, 
such as the coronary arteries, have also been described[3]. 
 In this article we conduct a systematic review of case reports and series of ADPKD patients who developed 
coronary artery dissection or aneurysm and include the case of a patient followed in our centre. 
 
2. Materials and Methods  
2.1. Case report 
 The case report was prepared after patient consent as defined by the ethical guidelines at Centro Hospitalar 
Lisboa Norte, Portugal. Data was gathered retrospectively from medical records. For the purposes of case reporting 
we used STROBE[4] and CARE guidelines[5]. 
2.2. Systematic review 
 The systematic review was conducted in line with MOOSE[6] and PRISMA[7] statements. The study 
protocol was published at PROSPERO (CRD42015015723; available at: 
http://www.crd.york.ac.uk/PROSPERO_REBRANDING/display_ 
record.asp?ID=CRD42015015723). 
2.2.1. Eligibility criteria 
All case reports and case series reporting original cases of pediatric and adult ADPKD patients with coronary 
artery dissection or aneurysm were accepted. Only published data was accepted. Other types of studies, and abstracts 
oral or poster presentations were excluded. There were no language or time restrictions and non-English reports were 
translated. 
2.2.2. Definitions 
In at-risk individuals, ADPKD diagnosis was based on the presence of: at least three renal cysts unilaterally 
or bilaterally in individuals between 15 and 39 years old; at least two cysts in each kidney in individuals between 40 
and 59 years old; and of four or more cysts in each kidney in individuals over 60 years old[8]. 
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 Coronary artery dissection was defined as: contrast dye staining of arterial wall with multiple radiolucent 
lumen; or appreciable (often subtle) abrupt change in arterial caliber, with demarcation from normal diameter to 
diffuse narrowing; or long (11–20 mm), hazy or linear stenosis without evidence of atherosclerotic changes in other 
coronary arteries[9]. 
 The definition of coronary artery aneurysm or ectasia used was: focal or segmental dilation that exceeds by 
50% the diameter of healthy adjacent reference segments or vessels[10]. Focal or segmental dilations of inferior 
diameter, sometimes mentioned as “minor ectasias”, were not considered for analysis. 
2.2.3. Data sources 
Electronic database identification of reports was conducted on MEDLINE and Web of Science. Grey 
literature was searched via appropriate databases (i.e.: OpenGrey). The last search was done on 27 December 2014. 
Whenever needed authors were contacted via email for further access to data. References of included studies were 
crosschecked. 
2.2.4. Search strategy 
The developed search strategy for all databases combined the terms (Autosomal Dominant Polycystic Kidney 
Disease) with (Coronary Artery Diseases OR Coronary Aneurysm OR Coronary Dissection). A highly sensitive filter 
was used to avoid retrieval of non-observational studies[11]. Participants were restricted to humans. All terms were 
searched as free-text and controlled vocabulary. The reference lists of selected studies were crosschecked for 
additional potentially eligible studies and cited reference research was done using studies’ titles and authors.  
2.2.5. Study selection 
Reports retrieved through electronic identification were screened for eligibility by title and abstract analysis. 
Exclusion reasons were not recorded. The full text of potentially eligible studies was screened for appropriateness for 
inclusion. Exclusion reasons were recorded. Two screeners (FBR, JBN) conducted this process. Disagreements were 
solved by consensus or by a third party (JAL). The Cohen’s kappa (κ) coefficient was used to calculate inter-observer 
bias[12]. 
2.2.6. Data extraction 
Two independent parties (FBR, JBN) extracted data from the included studies’ full text to an electronic form. 
Disagreements were solved by consensus or by a third party (JAL). 
2.2.7. Data synthesis and analysis 
  The following data were extracted: surname of first author, publication year, clinical characteristics, 
presence and family history of extra-renal ADPKD manifestations, diagnosis of coronary dissection or aneurysm, 
local treatment, and outcome. Gathered data were subject to descriptive analysis. 
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3. Results 
3.1. Case report 
 We report the case of a female Portuguese patient, with 41 years old, and a diagnosis of ADPKD with renal 
and hepatic cysts, without mutation analysis. Currently overweight (body mass index 28 kg/m2), the patient had 
normal renal function and no other cardiovascular risk factors, namely arterial hypertension. Her family history was 
remarkable for ADPKD: her father and brother had renal cysts but no extra-renal manifestations. 
 The patient was asymptomatic until 1 week before admission, when she started complaining of progressively 
worsening precordial discomfort with irradiation to both upper limbs. She went to see her family physician, where an 
electrocardiogram (EKG) was ordered. An elevation of the ST segment on DIII and aVF leads prompted the diagnosis 
of inferior myocardial infarction. The patient was then transferred to a central hospital, where an urgent coronary 
catheterization showed a co-dominant system, with 99% stenosis of the circumflex artery suggestive of either diffuse 
or spastic disease and 30% ostial stenosis of the right coronary artery. Balloon angioplasty was performed on the 
circumflex artery, with an end-thrombolysis in myocardial infarction (TIMI) flow grade of 3. 
 The patient remained asymptomatic for 6 days, after which anterior thoracic discomfort recurred. The EKG 
remained unchanged but troponin I levels raised from normal values to 2.45ng/ml (laboratory cut-off: 0.02ng/ml). A 
second coronary catheterization was performed, revealing a permeable circumflex artery despite complete right 
coronary artery occlusion due to dissection (Figure 1a). Reperfusion was accomplished after proximal placement of a 
drug-eluting stent under optical coherence tomography (OCT) guidance, with an end-TIMI flow grade of 3 (Figure 
1b). Thereafter the patient became asymptomatic and troponin I levels progressively normalized.  
 At two months of follow-up, coronary catheterization demonstrated maintenance of dissection of the right 
coronary artery (Figure 2a). Two drug-eluting stents were placed distally to the first under OCT guidance with an end-
TIMI flow grade of 3, except for the distal part of the vessel, which was very thin and remained dissected (Figure 2b). 
At six months of follow-up, the patient remained asymptomatic.  
3.2. Systematic review 
3.2.1. Study selection 
Database and manual search yielded 113 records. After deduplication, 103 records were screened and 84 
were discarded after title and abstract inspection due to lack of eligibility. A κ of 0.70 (95%CI 0.50-0.90) was 
calculated for inter-observer bias, reflecting good agreement between screeners[12]. Of the 19 potentially eligible 
studies, the full text was unavailable for 1, even after contacting the first author and the journal editor. The full text of 
18 potentially eligible studies was analyzed: 1 was excluded due to lack of eligibility criteria and 17 were included for 
analysis[13-29] (Figure 3). 
3.2.2. Study characteristics 
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All included studies were case reports except for three cases series[15-17]. All were in English but one 
published in Portuguese[25]. Publication years ranged from 1993 to 2014. The studies had widespread distribution: 6 
in Europe (Sweden, Germany, The Netherlands, Switzerland, France, and Italy), 6 in Asia (Israel, China, Iran, Japan, 
Turkey, and Korea), 3 in America (USA, and Brazil) and 2 in Oceania (Australia). 
3.3.  Analysis of study participants characteristics 
 The included studies reported on 23 patients but one had insufficient data regarding one patient[16]. After 
unsuccessful author contact, the latter patient was excluded from analysis.  
 Patient data extracted from the selected studies and from the case reported in this article are summarized on 
tables 1 and 2, representing a total of 23 patients: 7 (30.4%) with coronary artery dissection and 16 (69.6%) with 
coronary artery aneurysm. Genetic status was unknown for all patients. 
3.3.1. Manifestations, diagnosis, and treatment of ADPKD patients with coronary artery dissection 
 Most patients were female (n=5; 71.4%). The median age of diagnosis was 41 years (range: 36-59). Extra-
renal manifestations of ADPKD were reported as follows: two patients had hepatic cysts (patients 1, and 6), one had 
cardiac valvulopathies (patient 2 had mitral valve prolapse and regurgitation, and tricuspid valve prolapse), and none 
had extra-coronary aneurysms or dissections. 
 End-stage renal disease (ESRD) was absent in all coronary dissection patients. Arterial hypertension was 
diagnosed in two patients (28.6%) and coronary atherosclerosis was described in another two patients, one of them on 
the same dissected artery (left anterior descending artery on patient 5). None of the cases reported association with 
connective tissue disorders, systemic inflammatory diseases, or the peripartum period. In one (patient 2) the use of 
combined hormone therapy was registered. 
 None of the patients had a positive family history of coronary or extra-coronary aneurysms or dissections. 
 All cases were symptomatic: two patients (28.6%) had angina and five (71.4%) had a myocardial infarction. 
The primary method of diagnosis was coronary angiography (n=7, 100%). In one case (14.3%), computer tomography 
coronary angiography was also diagnostic. The most frequently affected artery was the left anterior descending vessel 
(n=5; 71.4%). 
 Coronary angioplasty was conducted on 4 patients (57.1%), with good control of symptoms in 3 patients. 
Outcome was not reported in all patients with conservative management and in one who underwent angioplasty. 
3.3.2. Manifestations, diagnosis, and treatment of ADPKD patients with coronary artery aneurysm 
 Male predominance was registered in coronary aneurysm patients (n=10; 76.9% of all patients with known 
gender). The median age of diagnosis was 44 years (range: 23-78). Extra-renal manifestations of ADPKD were 
reported as follows: four patients had hepatic cysts (patients 8, 20, 22, and 23); five had cardiac valvulopathies 
(patients 8, and 23 had mitral valve prolapse; patients 17, 22, and 23 had mitral regurgitation; and patients 18, and 22 
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had aortic regurgitation); and four had extra-coronary aneurysms (patients 18, 21, and 23 had aortic aneurysms; 
patient 20 had aneurysms on one renal artery; patient 23 had bilateral femoral artery aneurysms; and patient 18 had 
bilateral iliac artery aneurysms).  
 Six patients had ESRD (patients 8, 17, and 18 were transplant recipients, and patients 9, 20, and 23 were on 
hemodialysis). Arterial hypertension was diagnosed in five patients with coronary aneurysm (50% of all patients with 
reported blood pressure status). Six patients with coronary aneurysms had atherosclerosis, two of them on the same 
aneurysmatic artery (right coronary artery on patient 8 and right and left coronary arteries on patient 23). None of the 
cases reported association with connective tissue disorders, systemic inflammatory diseases, hormonal therapy, or the 
peripartum period. 
 A positive family history of coronary aneurysms was registered for patients 13, 14, 15, and 16. No family 
history of other aneurysmatic or dissecting complications was reported. 
 Six patients (46.1%) were asymptomatic. However four cases (30.8%) presented with myocardial infarction 
and three (23.1%) with angina. In 13 cases (81.3%), coronary aneurysms were diagnosed by coronary angiography. 
Three cases were diagnosed by other methods: one (6.3%) during autopsy, one (6.3%) with computer tomography 
coronary angiography, and one (6.3%) with transthoracic echocardiography.  
 In six cases (40%) multiple coronary arteries were aneurysmatic, with three-vessel aneurysms in three 
patients (20%). Overall, the right coronary was the most affected vessel (n=7), followed by the left anterior 
descending (n=6), and the circumflex artery (n=6). 
 Local treatment was reported in a single patient (patient 11): a coronary bypass surgery that, due to operative 
complications, lead to patient death. Two other patients died, one due to sepsis (patient 18) and another due to rupture 
of the coronary aneurysm (patient 21). Regarding the remaining patients, only two reported outcomes and both 
remained asymptomatic at follow-up (patients 22 and 23).  
 
4. Discussion 
 In this study we report and systematically analyze previous reports of coronary dissection and aneurysm in 
ADPKD patients. 
 Cardiovascular disease is the main cause of death among ADPKD patients, with half of the mortality cases 
being attributable to ischemic heart disease[30]. Ischemic heart disease is highly prevalent in ADPKD and is present 
even before ESRD[31]. However, coronary atherosclerosis may not be the sole source of cardiac associated-morbidity 
and mortality in ADPKD. As the present study shows, coronary artery dissections and aneurysms also represent a 
cause of angina, myocardial infarction, and death in ADPKD patients. 
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 Polycystin-1 and -2, the two mutated proteins responsible for ADPKD[2], are expressed in smooth muscle 
cells and myofibroblasts of the tunica media and in the endothelial layer of vessels[32]. It has been proposed that 
mutation of either of these proteins could contribute to vascular wall weakness[32]. An autopsy analysis revealed 
focal media defects on extracranial arteries that could represent precursor lesions of aneurysms[24]. Thus, mutation of 
ADPKD-related genes could be responsible for an arteriopathy that predisposes to aneurysm formation or vessel wall 
dissection. 
 Concerning the clinical case here reported we must acknowledge that, especially without access to images 
from the first coronary angiography, it is difficult to classify the right coronary artery dissection culpable for the 
second coronary syndrome as spontaneous or secondary to endovascular manipulation. Spontaneous coronary artery 
dissections are rare events. However, in this case balloon angioplasty was only performed on the circumflex artery 
and the rates of dissection solely due to guide-wire insertion are also low. Even if the dissection was triggered by the 
angiographic manipulation, we cannot ascertain whether the patient already had vessel weakness – either due to 
atherosclerosis or due to an arteriopathy caused by mutation of ADPKD genes. 
  With regards to coronary artery dissection, the findings of the present study are in line with previous reports 
for non-ADPKD patients, such as female predominance, age of presentation before 50 years old and left anterior 
descending as the most affected artery[33]. Coronary atherosclerosis and use of hormonal therapy[33] were the only 
potentially predisposing factors of coronary artery dissection denoted here. Despite previous reports of familial 
association of aortic dissections on ADPKD individuals[34], we did not observe the same for coronary dissections.  
 In the majority of the cases described, including the clinical case reported, percutaneous intervention with 
stent placement was the therapy of choice and provided good symptomatic relief. Nevertheless, half of patients 
maintained a dissected vessel on follow-up. The overall success rate described for percutaneous intervention in 
dissection is poor[33] and spontaneous resolution has also been described after dissection[35]. 
 As far as coronary aneurysms in ADPKD patients are concerned, a controlled case series has reported a 
higher prevalence than in the general population undergoing coronary angiography[16]. In accordance to previous 
reports[36, 37], we registered male predominance, frequent concomitant presence of atherosclerosis and arterial 
hypertension and right coronary artery predominance. However, the median age at diagnosis was lower than expected 
– we observed a median age of diagnosis of 44 years and previous reports on general population note that only 16% of 
patients are diagnosed before reaching 50 years old[38]. Multiple coronary artery involvement was also more frequent 
than reported for non-ADPKD patients[36, 37], and high rates of personal and family history of aneurysmatic burden 
on other extracranial vessels were registered.  
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 Only one ADPKD patient with coronary aneurysm underwent coronary bypass surgery. The largest 
therapeutic experience with coronary aneurysms is still surgical[36] but recent, minimally-invasive, percutaneous 
treatments to exclude the aneurysm appear to lead to reduced complication rates[39]. 
 Whilst the clinical characteristics of coronary dissection in ADPKD patients appear to mimic the ones for 
non-ADPKD individuals, we believe that the younger age at diagnosis, the aneurysmatic involvement of other vessels, 
the high family burden and the more frequent involvement of multiple arteries suggest a different mechanism of 
aneurysm formation as compared to the population without ADPKD diagnosis.  
 The clinical course of coronary aneurysms can be complicated by thrombosis, thromboembolism, formation 
of arteriovenous fistulae, vasospasm, and rupture[36]. We registered a high rate of myocardial infarction-associated 
diagnosis, and a complicated aneurysm and an operative complication as causes of death of two of the reported 
patients. Further studies are needed to confirm if coronary artery aneurysms confer worse outcomes to ADPKD 
patients and if asymptomatic diagnosis is worthwhile to prevent deleterious events. 
 Finally, the reported proportions of patients with arterial hypertension and coronary atherosclerosis in this 
systematic review are lower (<50%) than their incidence in non-ESRD ADPKD patients[40, 41]. This indicates that 
these may not have been predisposing factors for coronary abnormalities and that other sources of vessel weakness 
may be at play. 
4.1. Study limitations 
The limitations of the present analysis are the lack of access to all published cases, the small number of 
patients, the short-follow up and the incomplete outcome reporting of most studies. However, its systematic nature 
allows for conclusions of greatly enhanced quality. 
 
5. Conclusions 
 Mutation of ADPKD-related genes could lead to an arteriopathy that predisposes to coronary artery 
abnormalities. Atherosclerosis may not be the sole source of cardiac associated-morbidity and mortality in ADPKD 
since dissections and aneurysms also represent a cause of angina, myocardial infarction, and death in ADPKD 
patients. This study highlights the need for more extensive analysis to evaluate the prevalence, risk factors and 
adequate intervention in these individuals – analysis of data from patients included in the CRISP cohort[42] and 
HALT-PKD trials[43] may help further elucidate on these matters. 
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Legend of figures 
 
 
Figure 1. Coronary angiography showing a) proximal dissection of the right coronary artery and b) reperfusion after 
proximal drug-eluting stent placement. 
  
 
Figure 2. Coronary angiography showing a) middle and distal dissection of the right coronary artery and b) 
reperfusion after placement of two drug-eluting stents after the previously placed proximal stent. 
  
 
Figure 3. Study selection flow diagram according to PRISMA 2009 
 
